2026. Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients with Hyperuricemia: A Systematic Review. JURNAL FARMASIMED (JFM). 9, 1 (Oct. 2026), 157–162. DOI:https://doi.org/10.35451/jfm.v9i1.3890.